Literature DB >> 28838661

Transmission and Replication of Prions.

Alba Marín-Moreno1, Natalia Fernández-Borges1, Juan C Espinosa1, Olivier Andréoletti2, Juan M Torres3.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are a group of progressive, invariably fatal diseases that affect the nervous system of many mammals including humans. The key molecular event in the pathogenesis of TSEs is the conversion of the cellular prion protein PrPC into a disease-associated isoform PrPSc. The "protein-only hypothesis" argues that PrPSc itself is the infectious agent. In effect, PrPSc can adopt several structures that represent different prion strains. The interspecies transmission of TSEs is difficult because of differences between the host and donor primary PrP sequence. However, transmission is not impossible as this occurred when bovine spongiform encephalopathy spread to humans causing variant Creutzfeldt-Jakob disease (vCJD). This event determined a need for a thorough understanding of prion replication and transmission so that we could be one step ahead of further threats for human health. This chapter focuses on these concepts and on new insights gained into prion propagation mechanisms.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prion diseases; Prion replication; Prion strain; Prion transmission; Species barrier

Mesh:

Substances:

Year:  2017        PMID: 28838661     DOI: 10.1016/bs.pmbts.2017.06.014

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  6 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Cellular prion protein distribution in the vomeronasal organ, parotid, and scent glands of white-tailed deer and mule deer.

Authors:  Anthony Ness; Aradhana Jacob; Kelsey Saboraki; Alicia Otero; Danielle Gushue; Diana Martinez Moreno; Melanie de Peña; Xinli Tang; Judd Aiken; Susan Lingle; Debbie McKenzie
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

Review 3.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

4.  Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease.

Authors:  Jessy A Slota; Sarah J Medina; Megan Klassen; Damian Gorski; Christine M Mesa; Catherine Robertson; Gordon Mitchell; Michael B Coulthart; Sandra Pritzkow; Claudio Soto; Stephanie A Booth
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

5.  Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.

Authors:  Tomas Sneideris; Mantas Ziaunys; Brett K-Y Chu; Rita P-Y Chen; Vytautas Smirnovas
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

6.  Canine D163-PrP polymorphic variant does not provide complete protection against prion infection in small ruminant PrP context.

Authors:  Alba Marín-Moreno; Juan Carlos Espinosa; Patricia Aguilar-Calvo; Natalia Fernández-Borges; José Luis Pitarch; Lorenzo González; Juan María Torres
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.